Monday, July 19, 2010

Watch Out For FROI On Monday! Biotech Penny Stock Set to be a Huge Gainer for Savvy Investors.

Fero Industries, Inc. (OTCBB: FROI) recently closed the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.
FROI's Sucanon is one of only three approved drugs in the $5.6 billion dollar market for a class of diabetic medications called "Insulin Sensitizers".
cli

5-Star Pick Acquires One of Only Three Approved Drugs in the $5.6 billion Market.

Fellow investors, if you were ever looking for a ground floor opportunity bio-pharma deal that could hit the ground running, FROI is it! We have never seen a company positioned so perfectly is the right place at the right time; which is why FROI has earned our highest rating of 5 out of 5 Stars.
Diabetes currently affects over 285 million people worldwide and is expected to reach 438 million in 2030. FROI has acquired one of only three approved drugs in the $5.6 billion dollar market for a class of diabetic medications called "Insulin Sensitizers". The question for Savvy investors is, "How much of that $5.6 billion per year can FROI enhance its income statement by"? A mere 1% or $56,000,000 would give FROI Earnings per Share of $0.46 per share!
So do not wait, a small investment in FROI could yield short term profits of 300%, or more, and a lot more over the next few months. You could turn $500 into $2,000, maybe even as much as $5,000 dollars by getting in now.
rma



Posted by suprastock at 7/19/2010 07:20:00 AM

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)